新闻稿标题:[COMPANY] to Present at [TRADE SHOW] in [LOCATION] on
[DATE](简单明了的新闻稿可以让记者和读者对新闻所要描述的内容一目了然)
Feb. 23, 2012 /PRNewswire-Asia/ — [COMPANY NAME], a leader in
[INDUSTRY], today announced that it will present at the [TRADE
SHOW] on [DATE]. (首段仍是新闻要素。注意句式可以这样写。)
............................................................................................................................................................................
Example I: TPI Attends 32nd Cowen's Healthcare Conference at Boston
CHENGDU, China, February 10, 2012 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the research, development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced that the Company is invited to attend the 32nd Cowen's Healthcare Conference which is to take place from Monday March 5th through Wednesday March 7th at the Boston Marriott Copley Place Hotel.
About TPI
Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI's pipeline targets various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.
For more information about TPI, please visit: http://www.tianyinpharma.com
Safe Harbor Statement
The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.
For more information, please visit: http://www.tianyinpharma.com, or email: ir@tpi.asia
Tel: +86-28-8551-6696 (Chengdu, China)
+86-134-3655-0011 (China)
Address:
Tianyin Pharmaceutical Inc.
23rd Floor, Unionsun Yangkuo Plaza
No. 2, Block 3, South Renmin Road
Chengdu , 610041
China
Example II: China Hydroelectric Corporation to Present at the Jefferies 2012 Global Clean Technology Conference on February 23, 2012
NEW YORK, Feb. 16, 2012 /PRNewswire-Asia-FirstCall/ -- China Hydroelectric Corporation (NYSE: CHC, CHCWS) ("China Hydroelectric" or the "Company"), an owner, developer and operator of small hydroelectric power projects in the People's Republic of China ("PRC"), today announced that it will present at and attend one-on-one meetings with investors at the Jefferies 2012 Global Clean Technology Conference to be held in New York, NY on Thursday, February 23rd. John E. Donahue, Vice President of Investor Relations at China Hydroelectric Corporation, will present at 1:15 pm.
Conference participation is by invitation only and registration is mandatory. For more information on the conference or to schedule a one-on-one meeting, please contact your Jefferies representative.
About China Hydroelectric Corporation
China Hydroelectric Corporation (NYSE: CHC, CHCWS) ("China Hydroelectric" or "the Company") is an owner and operator of small hydroelectric power projects in the People's Republic of China. Through its geographically diverse portfolio of operating assets, the Company generates and sells electric power to local power grids. Led by an international management team, the Company's primary business is to identify, evaluate, acquire, develop, construct and finance hydroelectric power projects. The Company currently owns 26 operating hydropower stations in China with total installed capacity of 548 MW, of which it acquired 22 operating stations and constructed four. These hydroelectric power projects are located in four provinces: Zhejiang, Fujian, Yunnan andSichuan. Hydropower is an important factor in meeting China's electric power needs, accounting for approximately 22% of total nation-wide capacity.
For further information about China Hydroelectric Corporation, please visit the Company's website athttp://www.chinahydroelectric.com.
For further information, please contact:
|
|
|
|
|
|
|
|
|
Company:
|
|
|
|
John E. Donahue, VP of Investor Relations
|
|
China Hydroelectric Corporation
|
|
Phone: +1-646-467-9810
|
|
Email: john.donahue@chinahydroelectric.com
|
Email: scott.powell@hcinternational.net
|
|
|
|
|
TEMPLATE
[COMPANY] to Present at [TRADE SHOW] in [LOCATION] on [DATE]
Feb. 16, 2012 /PRNewswire-Asia/ -- [COMPANY NAME], a leader in [INDUSTRY], today announced that it will present at the [TRADE SHOW] on [DATE].
[PRESENTATION DETAILS]
[TRADE SHOW DETAILS]
[COMPANY BOILER]
CONTACT DETAILS]
来源:美通社
【微会展】QQ群:181752342.
【微会展】微信公众平台:V_MICE.
【微会展】资讯首发平台:@会展微刊 .